Prolongation of composite tissue allograft survival by immature recipient dendritic cells pulsed with donor antigen and transient low-dose immunosuppression

Plastic and Reconstructive Surgery

Volumn 121, Issue 1, 2008, Pages 37-49

  Sacks, Justin M ^a   Kuo, Yur Ren ^a   Taieb, Aurele ^a   Breitinger, Jeremy ^a   Nguyen, Vu T ^a   Thomson, Angus W ^a   Feili Hariri, Maryam ^a   Lee, W P Andrew ^a  

^a 690 Scaife Hall ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CYCLOSPORIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LYMPHOCYTE ANTIBODY;

ALLOGRAFT; ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELL LYSATE; CELL SEPARATION; COMPARATIVE STUDY; COMPOSITE GRAFT; CONTROLLED STUDY; DENDRITIC CELL; DESQUAMATION; EPIDERMOLYSIS; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY COMPLEX; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; MALE; MONONUCLEAR CELL; NONHUMAN; ORTHOTOPIC HIND LIMB TRANSPLANT; PRIORITY JOURNAL; RAT; SPLEEN CELL; TRANSPLANTATION;

ANIMALS; ANTIGENS; ANTILYMPHOCYTE SERUM; CYCLOSPORINE; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; MALE; RATS; RATS, INBRED LEW; RATS, INBRED WF; SPLEEN; TISSUE TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 38049095528     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000293754.55706.7f     Document Type: Article

References (39)

1. Lee, W. P. Composite tissue transplantation: More science and patience needed. Plast. Reconstr. Surg. 107: 1066, 2001.
2. Jones, N. F. Concerns about human hand transplantation in the 21st century. J. Hand Surg. (Am.) 27: 771, 2002.
3. Kaufman, D. B., Shapiro, R., Lucey, M. R., et al. Immunosuppression: Practice and trends. Am. J. Transplant. 4(Suppl. 9): 38, 2004.
4. Sayegh, M. H., and Carpenter, C. B. Transplantation 50 years later: Progress, challenges, and promises. N. Engl. J. Med. 351: 2761, 2004.
5. Lee, W. P., Yaremchuk, M. J., Pan, Y. C., et al. Relative antigenicity of components of a vascularized limb allograft. Plast. Reconstr. Surg. 87: 401, 1991.
6. Morelli, A. E., and Thomson, A. W. Dendritic cells: Regulators of alloimmunity and opportunities for tolerance induction. Immunol. Rev. 196: 125, 2003.
7. Groux, H., Fournier, N., and Cottrez, F. Role of dendritic cells in the generation of regulatory T cells. Semin. Immunol. 16: 99, 2004.
8. Rogers, N. J., and Lechler, R. I. Allorecognition. Am. J. Transplant. 1: 97, 2001.
9. Steinman, R. M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271, 1991.
10. Fu, F., Li, Y., Qian, S., et al. Costimulatory molecule-deficient dendritic cell progenitors(MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 62: 659, 1996.
11. Garrovillo, M., Ali, A., and Oluwole, S. F. Indirect allorecognition in acquired thymic tolerance: Induction of donorspecific tolerance to rat cardiac allografts by allopeptidepulsed host dendritic cells. Transplantation 68: 1827, 1999.
12. Garrovillo, M., Ali, A., Depaz, H. A., et al. Induction of transplant tolerance with immunodominant allopeptidepulsed host lymphoid and myeloid dendritic cells. Am. J. Transplant. 1: 129, 2001.
13. Taner, T., Hackstein, H., Wang, Z., et al. Rapamycin-treated, alloantigen-pulsed host dendritic cells induce ag-specific T cell regulation and prolong graft survival. Am. J. Transplant. 5: 228, 2005.
14. Peche, H., Trinite, B., Martinet, B., and Cuturi, M. C. Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors. Am. J. Transplant. 5: 255, 2005.
15. Feili-Hariri, M., Dong, X., Alber, S. M., et al. Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes 48: 2300, 1999.
16. Feili-Hariri, M., Falkner, D. H., and Morel, P. A. Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice. Eur. J. Immunol. 32: 2021, 2002.
17. Siemionow, M., Oke, R., Ozer, K., et al. Induction of donorspecific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol. J. Hand Surg. (Am.) 27: 1095, 2002.
18. Siemionow, M., Ortak, T., Izycki, D., et al. Induction of tolerance in composite-tissue allografts. Transplantation 74: 1211, 2002.
19. Sobrado, L., Pollak, R., Robichaux, W. H., et al. The survival and nature of the immune response to soft-tissue and com-posite-tissue allografts in rats treated with low-dose cyclosporine. Transplantation 50: 381, 1990.
20. Siemionow, M., Demir, Y., Mukherjee, A., and Klimczak, A. Development and maintenance of donor-specific chimerism in semi-allogenic and fully major histocompatibility complex mismatched facial allograft transplants. Transplantation 79: 558, 2005.
21. Lee, W. P., Butler, P. E., Randolph, M. A., and Yaremchuk, M. J. Donor modification leads to prolonged survival of limb allografts. Plast. Reconstr. Surg. 108: 1235, 2001.
22. Buttemeyer, R., Jones, N. F., Min, Z., and Rao, U. Rejection of the component tissues of limb allografts in rats immunosuppressed with FK-506 and cyclosporine. Plast. Reconstr. Surg. 97: 139, 1996.
23. Jones, N. F., Hebebrand, D., Buttemeyer, R., et al. Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: Implications for clinical composite tissue transplantation. Plast. Reconstr. Surg. 107: 777, 2001.
24. Sebille, F., Brouard, S., Petzold, T., et al. Tolerance induction in rats, using a combination of anti-CD154 and donor splenocytes, given once on the day of transplantation. Transplantation 75: 169, 2003.
25. Lu, L., Li, W., Fu, F., et al. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 64: 1808, 1997.
26. Foster, R. D., Fan, L., Neipp, M., et al. Donor-specific tolerance induction in composite tissue allografts. Am. J. Surg. 176: 418, 1998.
27. Siemionow, M. Z., Izycki, D. M., and Zielinski, M. Donorspecific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol. Transplantation 76: 1662, 2003.
28. Steinman, R. M., Hawiger, D., and Nussenzweig, M. C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685, 2003.
29. Hackstein, H., and Thomson, A. W. Dendritic cells: Emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 4: 24, 2004.
30. Morelli, A. E., Hackstein, H., and Thomson, A. W. Potential of tolerogenic dendritic cells for transplantation. Semin. Immunol. 13: 323, 2001.
31. Roelen, D. L., Schuurhuis, D. H., van den Boogaardt, D. E., et al. Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells. Transplantation 76: 1608, 2003.
32. Mirenda, V., Berton, I., Read, J., et al. Modified dendritic cells coexpressing self and allogeneic major histocompatability complex molecules: An efficient way to induce indirect pathway regulation. J. Am. Soc. Nephrol. 15: 987, 2004.
33. Gorantla, V. S., Barker, J. H., Jones, J. W., Jr., et al. Immunosuppressive agents in transplantation: Mechanisms of action and current anti-rejection strategies. Microsurgery 20: 420, 2000.
34. Wood, K. J., and Sakaguchi, S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3: 199, 2003.
35. Jones, J. W., Gruber, S. A., Barker, J. H., and Breidenbach, W. C. Successful hand transplantation: One-year follow-up. Louisville Hand Transplant Team. N. Engl. J. Med. 343: 468, 2000.
36. Inceoglu, S., Siemionow, M., Chick, L., et al. The effect of combined immunosuppression with systemic low-dose cyclosporin and topical fluocinolone acetonide on the survival of rat hind-limb allografts. Ann. Plast. Surg. 33: 57, 1994.
37. Elad, S., Or, R., Resnick, I., and Shapira, M. Y. Topical tacrolimus: A novel treatment alternative for cutaneous chronic graft-versus-host disease. Transpl. Int. 16: 665, 2003.
38. Margreiter, R., Brandacher, G., Ninkovic, M., et al. A doublehand transplant can be worth the effort! Transplantation 74: 85, 2002.
39. Niwa, Y., Terashima, T., and Sumi, H. Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin. Br. J. Dermatol. 149: 960, 2003.